Bausch and Lomb Newswire (Page 6)

Bausch and Lomb Newswire (Page 6)

Comprehensive Real-Time News Feed for Bausch and Lomb. (Page 6)

Results 101 - 120 of 540 in Bausch and Lomb

  1. Dow hits record high at market openRead the original story w/Photo

    Nov 7, 2017 | Reuters

    All three major indexes hit record levels in early trading on Tuesday as healthcare stocks rose on robust earnings and investors remained upbeat about a cut in corporate taxes. Trader Greg Rowe reacts after the closing bell on the floor of the New York Stock Exchange in New York City, New York, U.S., October 27, 2017.

    Comment?

  2. Wall Street hits new records as healthcare stocks riseRead the original story

    Nov 7, 2017 | Fox News

    All three major indexes hit record levels in early trading on Tuesday as healthcare stocks rose on robust earnings and investors remained upbeat about a cut in corporate taxes. Shares of Valeant Pharma surged 14.2 percent after the company's profit beat Wall Street estimates due to strength in its eye-care Bausch + Lomb business.

    Comment?

  3. Valeant spikes 13% after beating on the top and bottom linesRead the original story w/Photo

    Nov 7, 2017 | Silicon Alley Insider

    Valeant Pharmaceuticals International Inc reported a better-than-expected quarterly profit on strength in its Bausch and Lomb eye-care business, and the Canadian drugmaker maintained its full-year adjusted earnings forecast. Valeant maintained its forecast for full-year adjusted earnings before interest, taxes, depreciation and amortization of $3.60 billion to $3.75 billion, even as it divests assets to reduce its debt pile, accumulated during former CEO Michael Pearson's deal-making spree.

    Comment?

  4. UPDATE 2-Valeant profit beats on Bausch & Lomb strength, shares jumpRead the original story w/Photo

    Nov 7, 2017 | Reuters

    ) reported a better-than-expected quarterly profit on strength in its Bausch and Lomb eye-care business, and the Canadian drugmaker maintained its full-year adjusted earnings forecast. The headquarters of Valeant Pharmaceuticals International Inc is ...

    Comment?

  5. pSivida Corp. Builds Momentum During First Quarter FY18; Continues Operating Milestone ExecutionRead the original story

    Nov 7, 2017 | Customer Interaction Solutions

    Following a pre-NDA meeting with the FDA for Durasert three-year uveitis, which resulted in no changes to our proposed clinical data package, we continue to execute plans to file an NDA in late December 2017/early January 2018. Improved upon the existing collaboration agreement for ILUVIENA to change the terms of the arrangement to a net sales-based royalty to pSivida, effective as of July 1, 2017.

    Comment?

  6. Vitreoretinal Surgery Devices Market show exponential growth by 2027Read the original story w/Photo

    Nov 7, 2017 | PR-inside.com

    Vitreoretinal surgery is a surgery of the eye for treatment of complication related to retina, vitreous fluid and macula. Vitreoretinal surgery procedures commonly include retinal tears, diabetic retinopathy, retinal detachments, ocular trauma, macular degeneration, ocular tumor treatment and hereditary retinal disease treatment.

    Comment?

  7. Drug Device Combination Products Market to Register Substantial Expansion by 2027Read the original story w/Photo

    Nov 6, 2017 | PR-inside.com

    Drug device combination products are devices which consists medical device along with the pharmaceutical ingredient that helps to deliver the drug to desired location in the patient's body. These combination products have emerged as innovative medical devices owing to the contribution in advancing medical care and are thus expected to have major impact in the coming years.

    Comment?

  8. FDA Approves Vyzulta (latanoprostene bunod) Ophthalmic Solution for...Read the original story w/Photo

    Nov 2, 2017 | Drugs.com

    LAVAL, Quebec and SOPHIA ANTIPOLIS, France, Nov. 2, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc.'s wholly owned subsidiary, Bausch + Lomb, a leading global eye health company, and Nicox S.A. , an international ophthalmic company, today announced that the U.S. Food and Drug Administration has approved the New Drug Application for Vyzulta .

    Comment?

  9. Head to Head Review: Container StoreRead the original story w/Photo

    Nov 4, 2017 | Daily Political

    Container Store and Coastal Contacts are both consumer discretionary companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, earnings, analyst recommendations, valuation and profitability. Container Store has higher revenue and earnings than Coastal Contacts.

    Comment?

  10. Analyzing EVINE LiveRead the original story w/Photo

    Nov 4, 2017 | AmericanBankingNews.com

    EVINE Live and Coastal Contacts are both large-cap retail/wholesale companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership. 34.2% of EVINE Live shares are owned by institutional investors.

    Comment?

  11. Ocular Drug Delivery Technology Market to Expand at a Steady 6.8% CAGR Between 2017 and 2025Read the original story w/Photo

    Nov 1, 2017 | PR-inside.com

    Ocular Drug Delivery Technology Market report categorize the global market by Technology , Disease Type , End User & Geography A report by Transparency Market Research predicts the global ocular drug delivery technologies market to expand at a steady 6.8% CAGR between 2017 and 2025 to become worth US$18.124 bn by 2025-end vis-A -vis revenue from US$ 10.2 bn in 2016. Some of the primary growth drivers in the global ocular drug delivery technology market is the low bioavailability of drugs in conventional ocular therapies, increasing occurrence of glaucoma and macular degeneration, increasing preference among patients for targeted ocular drug delivery techniques, and approval of the FDA for new ocular drug delivery techniques.

    Comment?

  12. Know It AllRead the original story w/Photo

    Oct 28, 2017 | San Mateo Daily Journal

    One hundred years ago, the world population was 1.6 billion people. Today, it is more than 7.4 billion people.

    Comment?

  13. Ophthalmic devices Market to be growing at a CAGR of 6.20 %, to reach $ 44.76 billion by 2021Read the original story

    Oct 27, 2017 | Emailwire.com

    Ophthalmic devices Market by Product Type, by devices, By End Users , by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts Ophthalmic devices Market was worth $ 33.13 billion in 2016 and estimated to be growing at a CAGR of 6.20 %, to reach $ 44.76 billion by 2021 View report: Ophthalmology field needs medical devices for several functions such as vision care, diagnosis and surgery.

    Comment?

  14. This Tiny Massachusetts Biotech Could Reap Big Rewards for InvestorsRead the original story w/Photo

    Oct 26, 2017 | BioSpace

    With pending regulatory approval for its topical pain medication for the eye, analysts are taking a fond look at Kala Pharmaceuticals . On Wednesday, Kala submitted a New Drug Application to the U.S. Food and Drug Administration for Inveltys, a topical inflammation and pain treatment for patients who have undergone ocular surgery.

    Comment?

  15. pSivida: The Small Biotech With Big News ComingRead the original story w/Photo

    Oct 23, 2017 | Seeking Alpha

    Current and future investors should tune in at 8:30 AM ET for the call since pSivida will be covering significant company updates. I expect these updates to show that pSivida is making major progress in three key areas that will create positive stock price appreciation.

    Comment?

  16. Elderly and Disabled Assistive Equipment Market Sees Promising Growth in 2021Read the original story w/Photo

    Oct 18, 2017 | SBWire

    QYResearchReports.com announces the addition of a new research report, titled "Global Elderly and Disabled Assistive Equipment Market Research Report 2016." This study presents a comprehensive understanding of the market and also includes a thorough analysis of the segments such as product types and regions dominant in the market.

    Comment?

  17. pSivida Corp. Announces First Quarter Fiscal Year 2018 Financial...Read the original story

    Oct 18, 2017 | Customer Interaction Solutions

    Management will host a conference call to review the results at 8:30 a.m. ET on the same day. The conference call may be accessed by dialing 312-7507 from the U.S. and Canada, or 813-4828 from international locations.

    Comment?

  18. Ophthalmic Viscosurgical Devices Market to Witness Impressive Growth by 2025Read the original story

    Oct 17, 2017 | SBWire

    The global ophthalmic viscosurgical devices market is driven by the growing number of cataract procedures held worldwide. In addition to this, the lack of awareness among people regarding the need for regular eye checkups will also heighten the demand for ophthalmic viscosurgical devices in the future.

    Comment?

  19. Diabetic Macular Edema Market Competition and Development Insights with Forecast Up to 2027Read the original story w/Photo

    Oct 13, 2017 | SBWire

    The global diabetic macular edema market is projected to register a sluggish expansion at 1.1% CAGR through 2027, according to a report by Future Market Insights . The report estimates the market to reach US$ 3710.2 Mn in 2017; by 2027 this number is expected to surpass US$ 4,000 Mn.

    Comment?

  20. Glaucoma Surgery Market 2017 Estimated to Inflate with a Decent CAGR of 7.9 by 2023; Asserts MRFRRead the original story w/Photo

    Oct 13, 2017 | SBWire

    Executive Summary: Market Research Future published new report, titled "Glaucoma Surgery Market -Research Report: Global Forecast to 2023". Market Synopsis of Global Glaucoma Surgery Market Glaucoma is refer to a condition which causes blindness.

    Comment?